Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Levels of MicroRNA Heterogeneity in Cancer Biology
Nina Petrović, Sercan Ergün, Esma R. Isenović
Molecular Diagnosis & Therapy (2017) Vol. 21, Iss. 5, pp. 511-523
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
Margherita Ratti, Andrea Lampis, Michele Ghidini, et al.
Targeted Oncology (2020) Vol. 15, Iss. 3, pp. 261-278
Open Access | Times Cited: 380
Comparative analysis of chemical profiles, antioxidant, antibacterial, and anticancer effects of essential oils of two Thymus species from Montenegro
Kenan Preljević, Ivana Pašić, Milorad Vlaović, et al.
Fitoterapia (2024) Vol. 174, pp. 105871-105871
Closed Access | Times Cited: 9
mir-188‐5p emerges as an oncomir to promote chronic myeloid leukemia via upregulation of BUB3 and SUMO2
Osman Akıdan, Nina Petrović, Sema Mısır
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer
Jacek Kabziński, Monika Maczynska, Ireneusz Majsterek
Biomolecules (2021) Vol. 11, Iss. 6, pp. 844-844
Open Access | Times Cited: 47
miRNAs as Potential Treatment Targets and Treatment Options in Cancer
Nina Petrović, Sercan Ergün
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 2, pp. 157-168
Open Access | Times Cited: 53
miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2
Wentao Zhao, Xiaolin Lin, Yu Liu, et al.
Laboratory Investigation (2019) Vol. 99, Iss. 10, pp. 1484-1500
Open Access | Times Cited: 37
A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction
Janhavi R. Raut, Ben Schöttker, Bernd Holleczek, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 31
LncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancer
Honggang Sun, Liqin He, Lan Ma, et al.
Oncotarget (2017) Vol. 8, Iss. 66, pp. 110552-110565
Open Access | Times Cited: 34
Tumor Suppressor miR-584-5p Inhibits Migration and Invasion in Smoking Related Non-Small Cell Lung Cancer Cells by Targeting YKT6
Saet Byeol Lee, Young Soo Park, Jae Sook Sung, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1159-1159
Open Access | Times Cited: 24
Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells
Grazia Fenu, Carmen Griñán‐Lisón, Federica Etzi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2830-2830
Open Access
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes
Giuliana Ventriglia, Francesca Mancarella, Guido Sebastiani, et al.
Diabetologia (2019) Vol. 63, Iss. 1, pp. 124-136
Open Access | Times Cited: 28
Mir-23A Acts as An Oncogene in Pancreatic Carcinoma by Targeting Foxp2
Diao Hong-liang, Ye Zhou, Renyi Qin
Journal of Investigative Medicine (2017) Vol. 66, Iss. 3, pp. 676-683
Closed Access | Times Cited: 25
Non-coding RNAs in gynecologic cancer
Arezoo Solati, Sina Thvimi, Seyyed Hossein Khatami, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117618-117618
Closed Access | Times Cited: 8
miRNA‑125a‑5p inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting TP53 regulated inhibitor of apoptosis 1 and Bcl‑2‑like‑2 protein
Ming Ma, Ying Ma, Ling Ma
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 22
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma
Sara Carpi, Beatrice Polini, Stefano Fogli, et al.
Expert Review of Molecular Diagnostics (2019) Vol. 20, Iss. 1, pp. 19-30
Open Access | Times Cited: 20
Cancer‐specific risk prediction with a serum microRNA signature
Janhavi R. Raut, Megha Bhardwaj, Ben Schöttker, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 2049-2058
Open Access | Times Cited: 2
Establishment and validation of a 7-microRNA prognostic signature for non-small cell lung cancer
Nan Wang, Huihui� Guo, Zhaohuo Dong, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 3463-3471
Open Access | Times Cited: 20
Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
Lisa Linck, Claus Hellerbrand, Anja‐Katrin Bosserhoff, et al.
Cells (2020) Vol. 9, Iss. 1, pp. 114-114
Open Access | Times Cited: 17
Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front
Rikke Karlin Jepsen, Guy Wayne Novotny, Louise Laurberg Klarskov, et al.
Human Pathology (2018) Vol. 80, pp. 231-238
Open Access | Times Cited: 18
Circulating cell‐free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis
Beatrice Polini, Sara Carpi, Antonella Romanini, et al.
Pigment Cell & Melanoma Research (2018) Vol. 32, Iss. 4, pp. 486-499
Open Access | Times Cited: 18
Research progress on the relationship between zinc deficiency, related microRNAs, and esophageal carcinoma
Congmin Liu, Di Liang, Jing Jin, et al.
Thoracic Cancer (2017) Vol. 8, Iss. 6, pp. 549-557
Open Access | Times Cited: 17
Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity
Yvonne Gloor, Domitille Schvartz, Caroline Samer
Expert Opinion on Drug Metabolism & Toxicology (2019) Vol. 15, Iss. 8, pp. 659-669
Closed Access | Times Cited: 16
Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
Nina Petrović, Irina Nakashidze, Milica Nedeljković
Journal of Mammary Gland Biology and Neoplasia (2021) Vol. 26, Iss. 2, pp. 157-178
Closed Access | Times Cited: 13
Modulation of the dual‐faced effects of miR‐141 with chitosan/miR‐141 nanoplexes in breast cancer cells
Kübra Kaban, Emine Şalva, Jülide Akbuğa
The Journal of Gene Medicine (2019) Vol. 21, Iss. 9
Closed Access | Times Cited: 15
A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer
Chun‐Peng Liu, Jianhua Zhang, Shuai‐Chao Zheng, et al.
Oncology Reports (2018)
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top